6409-51-4

Basic information

• Product Name: 4-chloro-N-methyl-3-nitro-N-phenylbenzenesulphonamide
• Synonyms: 4-chloro-N-methyl-3-nitro-N-phenylbenzenesulphonamide;Benzenesulfonamide, 4-chloro-N-methyl-3-nitro-N-phenyl-;Einecs 229-083-3
• CAS NO: 6409-51-4
• Molecular Formula: C₁₃H₁₁ClN₂O₄S
• Molecular Weight: 326.75544
• EINECS: 229-083-3
• Mol File: 6409-51-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 470.4°C at 760 mmHg
• Flash Point: 238.3°C
• Appearance: /
• Density: 1.479g/cm³
• Vapor Pressure: 5.1E-09mmHg at 25°C
• Refractive Index: 1.64
• CAS DataBase Reference: 4-chloro-N-methyl-3-nitro-N-phenylbenzenesulphonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-chloro-N-methyl-3-nitro-N-phenylbenzenesulphonamide(6409-51-4)
• EPA Substance Registry System: 4-chloro-N-methyl-3-nitro-N-phenylbenzenesulphonamide(6409-51-4)

Safety Data

• Hazardous Substances Data: 6409-51-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C13H11ClN2O4S/c1-15(10-5-3-2-4-6-10)21(19,20)11-7-8-12(14)13(9-11)16(17)18/h2-9H,1H3

Upstream product

• 97-08-5 3-nitro-4-chlorosulfonyl chloride 
• 100-61-8 N-methylaniline 

Downstream Products

• 325986-10-5 3-amino-4-chloro-N-methyl-N-phenylbenzenesulfonamide 

Relevant articles and documents

ANTICOAGULANT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS TO TREAT THROMBOTIC CONDITIONS, AND PLASMA-SUBSTITUTING SOLUTION TO CORRECT HYPERCOAGULATION DEFECTS OF HEMODILUTION

This invention relates to new chemical compounds, application of these compounds as anticoagulants, pharmaceutical compositions, and plasma-substituting solutions on their basis, and can be used for treating thromboembolic complications of diseases such as myocardial infarction, stroke, and thrombosis of deep veins or a pulmonary artery; and for preventing hypercoagulation conditions in consequence of injuries, surgeries, sepsis, various obstetric pathologies, in disaster medicine, resuscitation, and so on.

FUSED PYRIMIDINE DERIVATIVE AND USE THEREOF

There are provided a fused pyrimidine compound having antagonistic activity against luteinizing hormone releasing hormone, and a medicine containing the compound. A luteinizing hormone releasing hormone antagonist containing a compound represented by the formula: wherein R1a is a hydrocarbon group which may be substituted or a hydrogen atom, ring Aa is a 6-membered aromatic ring which may be further substituted, ring Ba is a homocyclic or heterocyclic ring which may be further substituted, Wa is an oxygen atom or a sulfur atom, Xa1 and Xa2, which may be identical or different, are each a hydrogen atom, a hydrocarbon group which may be substituted, or a heterocyclic group which may be substituted, or Xa1 and Xa2 together may form an oxygen atom, a sulfur atom or NR3a (wherein R3a is a hydrocarbon group which may be substituted or a hydrogen atom), and Ya is C1-6 alkylene which may be substituted or a bond, or a salt or prodrug thereof.